+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
RGD Peptide Market - Global Forecast 2026-2032- Product Image
RGD Peptide Market - Global Forecast 2026-2032- Product Image
Sale

RGD Peptide Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6118031
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The RGD Peptide Market is projected to reach USD 299.55 Million in 2026. It is expected to continue growing at a CAGR of 10.06%, reaching USD 525.45 Million by 2032.

RGD Peptide Market: Executive Overview

RGD peptides are short amino-acid sequences containing arginine-glycine-aspartic acid that can bind selected integrins, including αvβ3 and α5β1. Their relevance spans targeted drug delivery, biomaterials, tissue engineering, imaging, and cell-adhesion research. The market is shaped by the need for selective biological interactions, reproducible synthesis, reliable characterization, and clinically appropriate delivery systems. Commercial progress depends on translating laboratory evidence into scalable, stable, and safe products while meeting quality and regulatory requirements.

How Targeted Biomaterials and Precision Delivery Are Reshaping RGD Peptides

The landscape is shifting from the use of RGD motifs as isolated research reagents toward their incorporation into multifunctional platforms. Researchers are combining RGD ligands with nanoparticles, hydrogels, implant coatings, scaffolds, and imaging agents to influence cell attachment, targeting, and tissue response. Key technical priorities include controlling ligand density, orientation, linker chemistry, degradation behavior, and off-target binding. These shifts increase the value of standardized peptide characterization and application-specific validation.

Artificial Intelligence Accelerates RGD Design, Screening, and Process Development

Artificial intelligence can support RGD peptide development by analyzing sequence-activity relationships, predicting peptide-integrin interactions, prioritizing conjugation strategies, and identifying experimental conditions for synthesis and purification. Machine-learning workflows may also help interpret imaging and cell-assay data, provided that training datasets are sufficiently diverse and experimentally validated. The strongest near-term value is likely to come from decision support that reduces screening effort while retaining laboratory confirmation. Data quality, interpretability, reproducibility, and protection of proprietary experimental data remain essential controls.

Regional Dynamics Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America benefits from established biotechnology, pharmaceutical, biomedical-engineering, and translational-research capabilities, supporting advanced peptide conjugates and integrin-focused applications. Europe combines strong academic research with detailed regulatory and quality expectations, encouraging robust characterization and responsible biomaterials development. Asia-Pacific is supported by expanding pharmaceutical manufacturing, materials research, and life-science infrastructure, with varied maturity across national markets. Latin America shows opportunities linked to academic collaboration, diagnostic research, and localized manufacturing, although access to specialized equipment and financing can differ. The Middle East is developing research and healthcare capabilities through institutional investment, while Africa’s progress is influenced by infrastructure availability, research partnerships, and access to specialized analytical services.

Group-Level Signals Across ASEAN, BRICS, the European Union, G7, GCC, and NATO

ASEAN presents a diverse combination of growing biomedical research, manufacturing capacity, and cross-border collaboration, making harmonized quality practices important. BRICS economies offer substantial scientific and industrial diversity, but regulatory pathways, infrastructure, and technology access vary considerably. The European Union emphasizes regulatory compliance, traceability, ethical research, and advanced biomaterials development. G7 members generally provide mature research ecosystems and strong translational capabilities, while also imposing rigorous evidence and quality expectations. GCC countries are strengthening life-science and healthcare infrastructure through investment and international partnerships. NATO members collectively represent a broad research and procurement environment in which dual-use considerations, supply-chain resilience, and secure data practices may affect advanced biomedical technologies.

Country-Level Priorities in Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, the United Kingdom, and

Australia and Canada provide strong opportunities for university-industry research and advanced biomaterials work. Brazil and Mexico have important academic and healthcare applications but may face uneven access to specialized peptide manufacturing and analytical capacity. China, India, Japan, and South Korea combine substantial research and manufacturing capabilities, with particular relevance to drug delivery, regenerative medicine, and engineered materials. France, Germany, Italy, Spain, and the United Kingdom offer established biomedical research bases and demanding quality frameworks. Russia has scientific capacity in selected fields, while supply, collaboration, and regulatory conditions require careful assessment. Across the United States, opportunities are supported by deep biotechnology, pharmaceutical, medical-device, and research infrastructure, alongside stringent expectations for reproducibility, safety, and translational evidence.

Actions for Leaders: Standardize, Validate, and Integrate RGD Peptide Platforms

Industry leaders should define application-specific performance criteria before selecting an RGD sequence, format, linker, or carrier. They should implement orthogonal analytical testing for identity, purity, aggregation, conjugation efficiency, stability, and biological activity, then connect those results to standardized cell-based assays. Partnerships with academic and clinical specialists can strengthen translational design, while qualified regional suppliers can improve continuity for critical raw materials and analytical services. Organizations should use artificial intelligence as a controlled, auditable aid rather than a substitute for experimental validation, and should establish governance for data provenance, model performance, cybersecurity, and regulatory documentation.

Methodology: Evidence-Based Review of RGD Peptide Applications and Enabling Technologies

This executive summary is based on the defined RGD peptide market scope and a structured assessment of publicly established scientific and industry themes related to RGD-mediated integrin binding, peptide synthesis, conjugation, biomaterials, targeted delivery, imaging, tissue engineering, artificial intelligence, regulation, and regional research capacity. Insights were synthesized across the required regions, country groupings, and countries. The assessment emphasizes documented mechanisms, development practices, infrastructure, and adoption considerations. It excludes market estimates, market sizing, market shares, forecasts, and unsupported claims about individual organizations.

Conclusion: RGD Peptides Depend on Translational Rigor and Application-Specific Design

RGD peptides occupy an enabling position across targeted delivery, biomaterials, regenerative medicine, imaging, and cell-interaction research. Their future relevance will depend less on the motif alone than on precise control of presentation, stability, selectivity, manufacturing quality, and biological validation. Regional capabilities differ, but common priorities include reproducible methods, robust supply chains, responsible artificial-intelligence use, and evidence aligned with regulatory expectations. Leaders that integrate peptide engineering with validated materials and delivery systems will be better positioned to convert RGD biology into reliable products and research tools.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. RGD Peptide Market, by Application
7.1. Introduction
7.2. Cell Adhesion Studies
7.3. Diagnostic Assays
7.4. Drug Delivery
7.5. Medical Device Coatings
7.6. Tissue Engineering
8. RGD Peptide Market, by End Use
8.1. Introduction
8.2. Academic Research
8.3. Biotechnology
8.4. Diagnostic
8.5. Pharmaceutical
9. RGD Peptide Market, by Type
9.1. Introduction
9.2. Cyclic
9.3. Linear
9.4. Modified
10. RGD Peptide Market, by Form
10.1. Introduction
10.2. Lyophilized
10.3. Powder
10.4. Solution
11. RGD Peptide Market, by Molecular Weight
11.1. Introduction
11.2. High Molecular Weight
11.3. Low Molecular Weight
11.4. Medium Molecular Weight
12. RGD Peptide Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. RGD Peptide Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. RGD Peptide Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AmbioPharm, Inc.
16.2. AnaSpec Inc.
16.3. Bachem Holding AG
16.4. Bio-Synthesis, Inc.
16.5. Biomatik Corporation
16.6. Biotage AB
16.7. CEM Corporation
16.8. Corden Pharma GmbH
16.9. CPC Scientific Inc.
16.10. Creative Peptides
16.11. CSBio Company, Inc.
16.12. GenScript Biotech Corporation
16.13. GL Biochem (Shanghai) Ltd.
16.14. Hybio Pharmaceutical Co. Ltd.
16.15. JPT Peptide Technologies
16.16. Merck KGaA
16.17. New England Peptide, Inc.
16.18. Peptides International, LLC
16.19. PolyPeptide Group
16.20. ProteoGenix
16.21. Scilight-Peptide Inc.
16.22. SynPeptide Co., Ltd.
16.23. Thermo Fisher Scientific Inc.
16.24. USV Private Limited
16.25. WuXi AppTec
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global RGD Peptide Market, Years Considered for the Study
FIGURE 2. Global RGD Peptide Market, Research Design
FIGURE 3. Global RGD Peptide Market, Research Framework
FIGURE 4. Global RGD Peptide Market, Data Triangulation
FIGURE 5. Global RGD Peptide Market Size, 2017-2032 (USD Million)
FIGURE 6. Global RGD Peptide Market Size, by Application, 2025 vs 2032 (%)
FIGURE 7. Global RGD Peptide Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global RGD Peptide Market Size, by End Use, 2025 vs 2032 (%)
FIGURE 9. Global RGD Peptide Market Size, by End Use, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global RGD Peptide Market Size, by Type, 2025 vs 2032 (%)
FIGURE 11. Global RGD Peptide Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global RGD Peptide Market Size, by Form, 2025 vs 2032 (%)
FIGURE 13. Global RGD Peptide Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global RGD Peptide Market Size, by Molecular Weight, 2025 vs 2032 (%)
FIGURE 15. Global RGD Peptide Market Size, by Molecular Weight, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global RGD Peptide Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global RGD Peptide Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global RGD Peptide Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global RGD Peptide Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global RGD Peptide Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global RGD Peptide Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global RGD Peptide Market Segmentation & Coverage
TABLE 2. Global RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 3. Global RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 4. Global Cell Adhesion Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cell Adhesion Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cell Adhesion Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Diagnostic Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Diagnostic Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Diagnostic Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Drug Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Drug Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Drug Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Medical Device Coatings Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Medical Device Coatings Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Medical Device Coatings Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Tissue Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Tissue Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Tissue Engineering Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 20. Global Academic Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Academic Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Academic Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Diagnostic Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Pharmaceutical Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Pharmaceutical Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Pharmaceutical Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 33. Global Cyclic Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Cyclic Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Cyclic Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Linear Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Linear Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Linear Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Modified Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Modified Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Modified Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 43. Global Lyophilized Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Lyophilized Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Lyophilized Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 53. Global High Molecular Weight Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global High Molecular Weight Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global High Molecular Weight Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Low Molecular Weight Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Low Molecular Weight Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Low Molecular Weight Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Medium Molecular Weight Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Medium Molecular Weight Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Medium Molecular Weight Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global RGD Peptide Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific RGD Peptide Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 69. North America RGD Peptide Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. North America RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 71. North America RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 72. North America RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 73. North America RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 74. North America RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 75. Latin America RGD Peptide Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Latin America RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 77. Latin America RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 78. Latin America RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 79. Latin America RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 80. Latin America RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 81. Europe RGD Peptide Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Europe RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 83. Europe RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 84. Europe RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 85. Europe RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 86. Europe RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 87. Middle East RGD Peptide Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Middle East RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Middle East RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 90. Middle East RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 91. Middle East RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 92. Middle East RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 93. Africa RGD Peptide Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Africa RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. Africa RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 96. Africa RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 97. Africa RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 98. Africa RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 99. Global RGD Peptide Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. ASEAN RGD Peptide Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. ASEAN RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. ASEAN RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 103. ASEAN RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 104. ASEAN RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 105. ASEAN RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 106. GCC RGD Peptide Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. GCC RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. GCC RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 109. GCC RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 110. GCC RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 111. GCC RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 112. European Union RGD Peptide Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. European Union RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. European Union RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 115. European Union RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 116. European Union RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 117. European Union RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 118. BRICS RGD Peptide Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. BRICS RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. BRICS RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 121. BRICS RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 122. BRICS RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 123. BRICS RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 124. G7 RGD Peptide Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. G7 RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. G7 RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 127. G7 RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 128. G7 RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 129. G7 RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 130. NATO RGD Peptide Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. NATO RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. NATO RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 133. NATO RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 134. NATO RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 135. NATO RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 136. Global RGD Peptide Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. United States RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 138. United States RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. United States RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 140. United States RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 141. United States RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 142. United States RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 143. Canada RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 144. Canada RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. Canada RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 146. Canada RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 147. Canada RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 148. Canada RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 149. Mexico RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 150. Mexico RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. Mexico RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 152. Mexico RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 153. Mexico RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 154. Mexico RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 155. Brazil RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 156. Brazil RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. Brazil RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 158. Brazil RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 159. Brazil RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 160. Brazil RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 161. United Kingdom RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 162. United Kingdom RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. United Kingdom RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 164. United Kingdom RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 165. United Kingdom RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 166. United Kingdom RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 167. Germany RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 168. Germany RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. Germany RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 170. Germany RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 171. Germany RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 172. Germany RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 173. France RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 174. France RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. France RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 176. France RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 177. France RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 178. France RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 179. Russia RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 180. Russia RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. Russia RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 182. Russia RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 183. Russia RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 184. Russia RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 185. Italy RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 186. Italy RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. Italy RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 188. Italy RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 189. Italy RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 190. Italy RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 191. Spain RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 192. Spain RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. Spain RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 194. Spain RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 195. Spain RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 196. Spain RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 197. China RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 198. China RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. China RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 200. China RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 201. China RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 202. China RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 203. India RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 204. India RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. India RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 206. India RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 207. India RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 208. India RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 209. Japan RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 210. Japan RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. Japan RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 212. Japan RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 213. Japan RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 214. Japan RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 215. Australia RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 216. Australia RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. Australia RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 218. Australia RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 219. Australia RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 220. Australia RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 221. South Korea RGD Peptide Market Size, 2017-2032 (USD Million)
TABLE 222. South Korea RGD Peptide Market Size, by Application, 2017-2032 (USD Million)
TABLE 223. South Korea RGD Peptide Market Size, by End Use, 2017-2032 (USD Million)
TABLE 224. South Korea RGD Peptide Market Size, by Type, 2017-2032 (USD Million)
TABLE 225. South Korea RGD Peptide Market Size, by Form, 2017-2032 (USD Million)
TABLE 226. South Korea RGD Peptide Market Size, by Molecular Weight, 2017-2032 (USD Million)
TABLE 227. Global RGD Peptide Market Share, by Key Player, 2025
TABLE 228. Global RGD Peptide Market, Key Experts

Companies Mentioned

  • AmbioPharm, Inc.
  • AnaSpec Inc.
  • Bachem Holding AG
  • Bio-Synthesis, Inc.
  • Biomatik Corporation
  • Biotage AB
  • CEM Corporation
  • Corden Pharma GmbH
  • CPC Scientific Inc.
  • Creative Peptides
  • CSBio Company, Inc.
  • GenScript Biotech Corporation
  • GL Biochem (Shanghai) Ltd.
  • Hybio Pharmaceutical Co. Ltd.
  • JPT Peptide Technologies
  • Merck KGaA
  • New England Peptide, Inc.
  • Peptides International, LLC
  • PolyPeptide Group
  • ProteoGenix
  • Scilight-Peptide Inc.
  • SynPeptide Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • USV Private Limited
  • WuXi AppTec

Related Topics

Related Reports

Bioactive Peptides Market - Global Forecast 2026-2032 - Product Image

Bioactive Peptides Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Bioactive Peptides - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Bioactive Peptides - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Bioactive Protein and Peptides Market Size, Share & Growth Analysis Report - Industry Trends, Competitive Landscape, Segment Insights (by Product Type, Application, End-User), and Forecast 2024-2034 - Product Image

Bioactive Protein and Peptides Market Size, Share & Growth Analysis Report - Industry Trends, Competitive Landscape, Segment Insights (by Product Type, Application, End-User), and Forecast 2024-2034

  • Report
  • 160 Pages
  • Global
From
Bioactive Peptide from Food Waste Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Bioactive Peptide from Food Waste Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 210 Pages
  • Global
From
Cyclic Peptides Market - Global Forecast 2026-2032 - Product Image

Cyclic Peptides Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.